Antibody responses to influenza A(H1N1)pdm infection

被引:3
|
作者
Wraith, Steph [1 ]
Nachbagauer, Raffael [3 ,4 ,5 ]
Balmaseda, Angel [6 ,7 ]
Stadlbauer, Daniel [3 ,4 ,5 ]
Ojeda, Sergio [7 ,8 ]
Rajabhathor, Arvind [3 ,4 ,5 ]
Lopez, Roger [6 ,7 ]
Guglia, Andrea F. [3 ,4 ,5 ]
Sanchez, Nery [7 ,8 ]
Amanat, Fatima [3 ,4 ,5 ]
Gresh, Lionel [7 ]
Kuan, Guillermina [7 ,8 ]
Krammer, Florian [3 ,4 ,5 ]
Gordon, Aubree [1 ,2 ,3 ]
机构
[1] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
[2] St Jude Ctr Excellence Influenza Res & Surveillan, Memphis, TN USA
[3] Ctr Excellence Influenza Res & Surveillance CEIRS, Memphis, TN USA
[4] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA
[5] Ctr Res Influenza Pathogenesis CRIP, New York, NY USA
[6] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua
[7] Sustainable Sci Inst, Managua, Nicaragua
[8] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua
关键词
Influenza; Antibodies; Neuraminidase; Hemagglutination inhibition; PROTECTION; VACCINE;
D O I
10.1016/j.vaccine.2020.04.069
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated humoral immune response to influenza A(H1N1)pdm infection and found 32 (22%) of the infected individuals identified by PCR failed to produce a >= 4-fold hemagglutinin inhibition assay (HAI) response; a subset of 18 (56%) produced an alternate antibody response (against full-length HA, HA stalk, or neuraminidase). These individuals had lower pre-existing HAI antibody titers and showed a pattern of milder illness. An additional subset of 14 (44%) did not produce an alternate antibody response, had higher pre-existing antibody titers against full-length & stalk HA, and were less sick. These findings demonstrate that some individuals mount an alternate antibody response to influenza infection. In order to design more broadly protective influenza vaccines it may be useful to target these alternate sites. These findings support that there are influenza cases currently being missed by solely implementing HAI assays, resulting in an underestimation of the global burden of influenza infection. (C) 2020 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4221 / 4225
页数:5
相关论文
共 50 条
  • [31] Critically Ill Patients With Influenza A(H1N1)pdm09 Virus Infection in 2014
    Napolitano, Lena M.
    Angus, Derek C.
    Uyeki, Timothy M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2014, 311 (13): : 1289 - 1290
  • [32] The novel influenza A/H1N1 or (2009) Influenza A/H1N1 or "Swine-origin influenza A (H1N1)"
    Cabezas Fernandez del Campo, Jose Antonio
    ANALES DE LA REAL ACADEMIA NACIONAL DE FARMACIA, 2009, 75 (04): : 947 - 963
  • [33] INFLUENZA A (H1N1) INFECTION AND COMPLICATED CASES
    Antonopoulou, E.
    Lefa, P.
    Papadaki, E.
    ACTA PAEDIATRICA, 2011, 100 : 81 - 81
  • [34] INFLUENZA A (H1N1) INFECTION IN CHILDREN WITH CANCER
    Gorender, Ethel
    Oliveira, Renato
    Arancibia, Alejandro
    Melaragno, Renato
    Meirelles, Priscila
    Epelman, Sidnei
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 953 - 953
  • [35] NOSOCOMIAL INFLUENZA-A (H1N1) INFECTION
    BALKOVIC, ES
    GOODMAN, RA
    ROSE, FB
    BOREL, CO
    AMERICAN JOURNAL OF MEDICAL TECHNOLOGY, 1980, 46 (05): : 318 - 320
  • [36] Influenza A (H1N1) infection and disseminated strongyloidiasis
    Canzian, M.
    Falcao, B. A. A.
    Lage, S. G.
    HISTOPATHOLOGY, 2010, 57 : 179 - 179
  • [37] Differences in Antibody Responses of Individuals with Natural Infection and Those Vaccinated against Pandemic H1N1 2009 Influenza
    Chan, Kwok-Hung
    To, Kelvin K. W.
    Hung, Ivan F. N.
    Zhang, Anna J. X.
    Chan, Jasper F. W.
    Cheng, Vincent C. C.
    Tse, Herman
    Che, Xiao-Yan
    Chen, Honglin
    Yuen, Kwok-Yung
    CLINICAL AND VACCINE IMMUNOLOGY, 2011, 18 (05) : 867 - 873
  • [38] Seropositivity to influenza A(H1N1) pdm09 and influenza A (H3N2) and risk of infection in health care workers
    Nandhini, G.
    Sujatha, S.
    CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH, 2016, 4 (01): : 28 - 32
  • [39] Neurological complications of pandemic A(H1N1)2009pdm, postpandemic A(H1N1)v, and seasonal influenza A
    Radzisauskiene, Daiva
    Vitkauskaite, Monika
    Zvinyte, Karolina
    Mameniskiene, Ruta
    BRAIN AND BEHAVIOR, 2021, 11 (01):
  • [40] Seasonal Human Influenza A(H3N2) and Influenza A(H1N1)pdm09 Reassortant Infection - Idaho, 2019
    Pedersen, Randi
    Barton, Vonnita
    Tripp, Jennifer
    Blanton, Lenee
    Barnes, John
    Hahn, Christine
    MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT, 2020, 69 (14): : 427 - 428